When examined by individual diagnoses, subjects who developed NHL had slightly higher mean CD4, CD8, and WBC trajectories compared to those who developed solid-tissue tumors and controls (Fig. 3). The gene discussed is CD4; the disease is non-Hodgkin lymphoma.